We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
-$692M
Cap. Flow %
-0.42%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.05%
2 Technology 7.69%
3 Financials 6.83%
4 Healthcare 6.42%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYPD
5051
Hyperion DeFi Inc
HYPD
$54.4M
$650K ﹤0.01%
1,659
+274
+20% +$102K
WEN icon
5052
PUT
Wendy's
WEN
$1.55B
$650K ﹤0.01%
30,000
MTCR
5053
DELISTED
Metacrine, Inc. Common Stock
MTCR
$650K ﹤0.01%
189,548
-71,872
-27% -$224K
FGBI icon
5054
First Guaranty Bancshares
FGBI
$137M
$649K ﹤0.01%
35,582
-6,847
-16% -$120K
NOAH
5055
Noah Holdings
NOAH
$590M
$649K ﹤0.01%
17,479
-57,991
-77% -$2.3M
SIFY
5056
Sify Technologies
SIFY
$1.05B
$648K ﹤0.01%
31,977
+13,065
+69% +$270K
ARCB icon
5057
ArcBest
ARCB
$3.12B
$646K ﹤0.01%
7,895
-39,441
-83% -$2.6M
CASS icon
5058
Cass Information Systems
CASS
$734M
$645K ﹤0.01%
15,421
-9,849
-39% -$419K
LITTU
5059
DELISTED
Logistics Innovation Technologies Corp. Units
LITTU
$645K ﹤0.01%
65,141
-414,929
-86% -$4.14M
ATCX
5060
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$645K ﹤0.01%
63,465
-109,481
-63% -$1.13M
ABUS icon
5061
CALL
Arbutus Biopharma
ABUS
$1.02B
$644K ﹤0.01%
+150,000
New +$500K
LOGC
5062
DELISTED
ContextLogic
LOGC
$644K ﹤0.01%
3,934
-21,658
-85% -$5.39M
VIHAW
5063
CALL
DELISTED
VPC Impact Acquisition Holdings Warrant
VIHAW
$644K ﹤0.01%
+400,000
New +$579K
SIBN icon
5064
PUT
SI-BONE Inc
SIBN
$868M
$643K ﹤0.01%
+30,000
New +$759K
MIO
5065
DELISTED
Pioneer Municipal High Income Opportunities Fund
MIO
$642K ﹤0.01%
+31,502
New +$633K
KALV
5066
DELISTED
KalVista Pharmaceuticals
KALV
$641K ﹤0.01%
+36,715
New +$744K
SCLX icon
5067
Scilex Holding
SCLX
$39.2M
$640K ﹤0.01%
1,830
+935
+104% +$326K
BWAC
5068
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$640K ﹤0.01%
63,536
+27,500
+76% +$276K
FMNB icon
5069
Farmers National Banc Corp
FMNB
$934M
$639K ﹤0.01%
40,689
+27,482
+208% +$422K
KMI icon
5070
PUT
Kinder Morgan
KMI
$70.5B
$639K ﹤0.01%
+38,200
New +$649K
LNC icon
5071
PUT
Lincoln National
LNC
$8.39B
$639K ﹤0.01%
9,300
-13,400
-59% -$875K
MIXT
5072
DELISTED
MIX TELEMATICS LIMITED
MIXT
$637K ﹤0.01%
51,769
-11,780
-19% -$160K
EVGOW
5073
CALL
DELISTED
EVgo Inc Warrants
EVGOW
$636K ﹤0.01%
363,150
IBRX icon
5074
ImmunityBio
IBRX
$8.65B
$636K ﹤0.01%
65,333
+1,686
+3% +$18.6K
MPX
5075
DELISTED
Marine Products Corp
MPX
$635K ﹤0.01%
+50,798
New +$740K

Similar funds

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.